Health TrialsbyHealthPanel

Adipokines in Polycystic Ovary Syndrome

ConditionsPCOSReproductive Age
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorJagiellonian University

About this trial

The aim of the study is to compare the concentrations of leptin, resistin, and omentin-1 in women across three research groups: those with polycystic ovary syndrome without insulin resistance, those with polycystic ovary syndrome with insulin resistance, and women without polycystic ovary syndrome.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18-45

Disqualifiers

previous removal of at least one ovary

treated diabetes of any type

diagnosed and treated metabolic diseases

diagnosed and treated autoimmune diseases

Trial population

women aged 18-45 years managed for menstrual irregularities or routine check-up

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Leptin concentration in blood serum

    Diagnostic test

    Fasting plasma leptin concentration measurement with results expressed in pg/ml and comparison across all study arms

  • Resistin concentration in blood serum

    Diagnostic test

    Fasting plasma resistin concentration measurement with results expressed in pg/ml and comparison across all study arms

  • Omentin-1 concentration in blood serum

    Diagnostic test

    Fasting plasma omentin-1 concentration measurement with results expressed in pg/ml and comparison across all study arms

Treatment groups

300 Participants
are divided into 3 treatment groups
Group A: PCOS+IR3 interventions
Group B: PCOS + no IR3 interventions
Group C: No PCOS3 interventions

Trial outcomes

Primary outcomes

1

Comparison of resistin concentration in three study groups

Measurement and comparison of mean fasting plasma resistin concentration expressed in pg/ml in three study groups

Time frame
up to 6 months
2

Comparison of leptin concentration three study groups

Measurement and comparison of mean fasting plasma leptin concentration expressed in pg/ml in three study groups

Time frame
up to 6 months
3

Comparison of omentin-1 concentration in three study groups

Measurement and comparison of mean fasting plasma omentin-1 concentration expressed in pg/ml in three study groups

Time frame
up to 6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jagiellonian University

Lead sponsor

Source ClinicalTrials.gov
Apply now